Giuseppe Orlando to Liver Transplantation
This is a "connection" page, showing publications Giuseppe Orlando has written about Liver Transplantation.
Connection Strength
4.100
-
Orlando G, Adam R, Mirza D, Soderdahl G, Porte RJ, Paul A, Burroughs AK, Seiler CA, Colledan M, Graziadei I, Garcia Valdecasas JC, Pruvot FR, Karam V, Lerut J. Hepatic hemangiosarcoma: an absolute contraindication to liver transplantation--the European Liver Transplant Registry experience. Transplantation. 2013 Mar 27; 95(6):872-7.
Score: 0.405
-
Orlando G, Wood KJ, Soker S, Stratta RJ. How regenerative medicine may contribute to the achievement of an immunosuppression-free state. Transplantation. 2011 Oct 27; 92(8):e36-8; author reply e39.
Score: 0.367
-
Orlando G, Soker S, Wood K. Operational tolerance after liver transplantation. J Hepatol. 2009 Jun; 50(6):1247-57.
Score: 0.307
-
Orlando G, Manzia T, Baiocchi L, Sanchez-Fueyo A, Angelico M, Tisone G. The Tor Vergata weaning off immunosuppression protocol in stable HCV liver transplant patients: the updated follow up at 78 months. Transpl Immunol. 2008 Nov; 20(1-2):43-7.
Score: 0.295
-
Orlando G, Baiocchi L, Cardillo A, Iaria G, De Liguori Carino N, De Liguori N, De Luca L, Ielpo B, Tariciotti L, Angelico M, Tisone G. Switch to 1.5 grams MMF monotherapy for CNI-related toxicity in liver transplantation is safe and improves renal function, dyslipidemia, and hypertension. Liver Transpl. 2007 Jan; 13(1):46-54.
Score: 0.263
-
Orlando G, Ferrant A, Schots R, Goffette P, Mathijs J, Lemaire J, Danse E, Talpe S, Latinne D, Lerut J. Liver transplantation for chronic graft-versus-host disease: case report with 10-year follow-up. Transpl Int. 2005 Jan; 18(1):125-9.
Score: 0.229
-
Orlando G, Blairvacq JS, Otte JB, Goffette P, Ciccarelli O, Sempoux C, Lerut J. Successful treatment of recurrent cholangitis after adult liver transplantation with a Tsuchida antireflux valve. Transplantation. 2004 Apr 27; 77(8):1307-8.
Score: 0.218
-
Orlando G, Lerut J, Samuel D, Bismuth H. Post-splenectomy pancreatic pseudocyst and extensive thrombosis of the portal venous system in a liver transplant recipient. J Hepatol. 2002 Jul; 37(1):161.
Score: 0.192
-
Orlando G, Lai Q, Lerut J. Composite hepatocellular and hemangiosarcomatous tumor: The prognosis is determined by the sarcomatous component. Hepatobiliary Pancreat Dis Int. 2020 Apr; 19(2):184-186.
Score: 0.161
-
Manzia TM, Angelico R, Toti L, Belardi C, Cillis A, Quaranta C, Tariciotti L, Katari R, Mogul A, Sforza D, Orlando G, Tisone G. The efficacy and safety of mammalian target of rapamycin inhibitors ab initio after liver transplantation without corticosteroids or induction therapy. Dig Liver Dis. 2016 Mar; 48(3):315-20.
Score: 0.122
-
Lerut JP, Pinheiro RS, Lai Q, Stouffs V, Orlando G, Juri JM, Ciccarelli O, Sempoux C, Roggen FM, De Reyck C, Latinne D, Gianello P. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. Ann Surg. 2014 Nov; 260(5):886-91; discussion 891-2.
Score: 0.113
-
Manzia TM, Angelico R, Baiocchi L, Toti L, Ciano P, Palmieri G, Angelico M, Orlando G, Tisone G. The Tor Vergata weaning of immunosuppression protocols in stable hepatitis C virus liver transplant patients: the 10-year follow-up. Transpl Int. 2013 Mar; 26(3):259-66.
Score: 0.099
-
Orlando G, Wood KJ, De Coppi P, Baptista PM, Binder KW, Bitar KN, Breuer C, Burnett L, Christ G, Farney A, Figliuzzi M, Holmes JH, Koch K, Macchiarini P, Mirmalek Sani SH, Opara E, Remuzzi A, Rogers J, Saul JM, Seliktar D, Shapira-Schweitzer K, Smith T, Solomon D, Van Dyke M, Yoo JJ, Zhang Y, Atala A, Stratta RJ, Soker S. Regenerative medicine as applied to general surgery. Ann Surg. 2012 May; 255(5):867-80.
Score: 0.095
-
Orlando G, Domínguez-Bendala J, Shupe T, Bergman C, Bitar KN, Booth C, Carbone M, Koch KL, Lerut JP, Neuberger JM, Petersen B, Ricordi C, Atala A, Stratta RJ, Soker S. Cell and organ bioengineering technology as applied to gastrointestinal diseases. Gut. 2013 May; 62(5):774-86.
Score: 0.093
-
Manzia TM, Gravante G, Di Paolo D, Orlando G, Toti L, Bellini MI, Ciano P, Angelico M, Tisone G. Liver transplantation for the treatment of nodular regenerative hyperplasia. Dig Liver Dis. 2011 Dec; 43(12):929-34.
Score: 0.089
-
Manzia TM, Bellini MI, Corona L, Toti L, Fratoni S, Cillis A, Orlando G, Tisone G. Successful treatment of systemic de novo sarcoidosis with cyclosporine discontinuation and provision of rapamune after liver transplantation. Transpl Int. 2011 Aug; 24(8):e69-70.
Score: 0.089
-
Manzia TM, Angelico R, Toti L, Bellini MI, Sforza D, Palmieri G, Orlando G, Tariciotti L, Angelico M, Tisone G. Long-term, maintenance MMF monotherapy improves the fibrosis progression in liver transplant recipients with recurrent hepatitis C. Transpl Int. 2011 May; 24(5):461-8.
Score: 0.087
-
Orlando G, Baptista P, Birchall M, De Coppi P, Farney A, Guimaraes-Souza NK, Opara E, Rogers J, Seliktar D, Shapira-Schweitzer K, Stratta RJ, Atala A, Wood KJ, Soker S. Regenerative medicine as applied to solid organ transplantation: current status and future challenges. Transpl Int. 2011 Mar; 24(3):223-32.
Score: 0.086
-
Lerut J, Mathys J, Verbaandert C, Talpe S, Ciccarelli O, Lemaire J, Bonaccorsi-Riani E, Vanthuyne V, Hetsch N, Roggen F, Reyck CD, Goffette P, Latinne D, Orlando G, Rahier J, Sempoux C, Wallemacq P, Laterre PF, Gianello P. Tacrolimus monotherapy in liver transplantation: one-year results of a prospective, randomized, double-blind, placebo-controlled study. Ann Surg. 2008 Dec; 248(6):956-67.
Score: 0.075
-
Gravante G, De Liguori Carino N, Overton J, Manzia TM, Orlando G. Primary carcinoids of the liver: a review of symptoms, diagnosis and treatments. Dig Surg. 2008; 25(5):364-8.
Score: 0.075
-
Martínez-Llordella M, Lozano JJ, Puig-Pey I, Orlando G, Tisone G, Lerut J, Benítez C, Pons JA, Parrilla P, Ramírez P, Bruguera M, Rimola A, Sánchez-Fueyo A. Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J Clin Invest. 2008 Aug; 118(8):2845-57.
Score: 0.073
-
Lerut JP, Orlando G, Adam R, Schiavo M, Klempnauer J, Mirza D, Boleslawski E, Burroughs A, Sellés CF, Jaeck D, Pfitzmann R, Salizzoni M, Söderdahl G, Steininger R, Wettergren A, Mazzaferro V, Le Treut YP, Karam V. The place of liver transplantation in the treatment of hepatic epitheloid hemangioendothelioma: report of the European liver transplant registry. Ann Surg. 2007 Dec; 246(6):949-57; discussion 957.
Score: 0.070
-
Lerut JP, Weber M, Orlando G, Dutkowski P. Vascular and rare liver tumors: a good indication for liver transplantation? J Hepatol. 2007 Oct; 47(4):466-75.
Score: 0.068
-
Lerut J, Orlando G, Adam R, Sabbà C, Pfitzmann R, Klempnauer J, Belghiti J, Pirenne J, Thevenot T, Hillert C, Brown CM, Gonze D, Karam V, Boillot O. Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry. Ann Surg. 2006 Dec; 244(6):854-62; discussion 862-4.
Score: 0.065
-
Tisone G, Orlando G, Angelico M. Operational tolerance in clinical liver transplantation: emerging developments. Transpl Immunol. 2007 Feb; 17(2):108-13.
Score: 0.065
-
Baiocchi L, Angelico M, De Luca L, Ombres D, Anselmo A, Telesca C, Orlando G, D'Andria D, Tisone G. Cyclosporine A versus tacrolimus monotherapy. Comparison on bile lipids in the first 3 months after liver transplant in humans. Transpl Int. 2006 May; 19(5):389-95.
Score: 0.063
-
Tisone G, Orlando G, Cardillo A, Palmieri G, Manzia TM, Baiocchi L, Lionetti R, Anselmo A, Toti L, Angelico M. Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence. J Hepatol. 2006 Apr; 44(4):702-9.
Score: 0.061
-
Orlando G, Goffette P, Geubel A, Lerut J. Vaginal bleeding complicating portal hypertension: a particular entity - report of two cases and review of the literature. Transpl Int. 2005 Dec; 18(12):1382-5.
Score: 0.061
-
Lerut J, Ciccarelli O, Rutgers M, Orlando G, Mathijs J, Danse E, Goffin E, Gigot JF, Goffette P. Liver transplantation with preservation of the inferior vena cava in case of symptomatic adult polycystic disease. Transpl Int. 2005 May; 18(5):513-8.
Score: 0.059
-
Lerut JP, Orlando G, Sempoux C, Ciccarelli O, Van Beers BE, Danse E, Horsmans Y, Rahier J, Roggen F. Hepatic haemangioendothelioma in adults: excellent outcome following liver transplantation. Transpl Int. 2004 May; 17(4):202-7.
Score: 0.055